# Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer：Multicenter Controlled Study.(RadmiR-01)

> **NCT03074175** · NA · COMPLETED · sponsor: **Xinqiao Hospital of Chongqing** · enrollment: 240 (actual)

## Conditions studied

- Advanced Nsclc

## Interventions

- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT03074175
- **Lead sponsor:** Xinqiao Hospital of Chongqing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-12-31
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03074175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03074175, "Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer：Multicenter Controlled Study.(RadmiR-01)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03074175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*